Security Description | | Shares | | | Value | |
COMMON STOCKS - 99.1% | | | | | | | | |
Health Care - 99.1% | | | | | | | | |
ACADIA Pharmaceuticals, Inc.* | | | 21,826 | | | $ | 415,130 | |
ADMA Biologics, Inc.* | | | 30,552 | | | | 375,178 | |
Agios Pharmaceuticals, Inc.* | | | 7,042 | | | | 326,749 | |
Alnylam Pharmaceuticals, Inc.* | | | 2,058 | | | | 488,693 | |
Amgen, Inc. | | | 1,103 | | | | 366,714 | |
Amicus Therapeutics, Inc.* | | | 30,939 | | | | 318,981 | |
Apellis Pharmaceuticals, Inc.* | | | 7,738 | | | | 306,425 | |
Ardelyx, Inc.* | | | 50,747 | | | | 281,646 | |
Ascendis Pharma A/S (Denmark)*(1) | | | 2,576 | | | | 343,896 | |
Aurinia Pharmaceuticals, Inc. (Canada)* | | | 61,561 | | | | 361,979 | |
Axsome Therapeutics, Inc.*(2) | | | 4,542 | | | | 396,562 | |
BeiGene Ltd. (China)*(1) | | | 1,979 | | | | 329,662 | |
BioCryst Pharmaceuticals, Inc.* | | | 52,865 | | | | 384,857 | |
Biogen, Inc.* | | | 1,408 | | | | 300,186 | |
BioMarin Pharmaceutical, Inc.* | | | 3,910 | | | | 329,730 | |
BioNTech SE (Germany)*(1) | | | 3,431 | | | | 295,752 | |
Blueprint Medicines Corp.* | | | 3,096 | | | | 335,297 | |
Bridgebio Pharma, Inc.*(2) | | | 11,357 | | | | 294,714 | |
CRISPR Therapeutics AG (Switzerland)*(2) | | | 5,047 | | | | 289,143 | |
Day One Biopharmaceuticals, Inc.* | | | 25,491 | | | | 364,776 | |
Dynavax Technologies Corp.* | | | 27,423 | | | | 306,863 | |
Esperion Therapeutics, Inc.*(2) | | | 113,178 | | | | 261,441 | |
Exelixis, Inc.* | | | 14,998 | | | | 351,703 | |
Geron Corp.* | | | 67,490 | | | | 319,903 | |
Gilead Sciences, Inc. | | | 5,182 | | | | 394,143 | |
Halozyme Therapeutics, Inc.* | | | 6,637 | | | | 366,761 | |
Harmony Biosciences Holdings, Inc.*(2) | | | 11,067 | | | | 374,729 | |
ImmunityBio, Inc.*(2) | | | 56,107 | | | | 288,951 | |
Immunocore Holdings PLC (United Kingdom)*(1)(2) | | | 8,298 | | | | 329,431 | |
Incyte Corp.* | | | 5,254 | | | | 341,878 | |
Insmed, Inc.* | | | 5,344 | | | | 388,776 | |
Intra-Cellular Therapies, Inc.* | | | 4,814 | | | | 378,958 | |
Ionis Pharmaceuticals, Inc.* | | | 8,009 | | | | 396,125 | |
Iovance Biotherapeutics, Inc.* | | | 39,069 | | | | 341,072 | |
Ironwood Pharmaceuticals, Inc.* | | | 55,075 | | | | 376,162 | |
Kiniksa Pharmaceuticals International PLC* | | | 17,556 | | | | 466,990 | |
Krystal Biotech, Inc.*(2) | | | 1,802 | | | | 375,645 | |
Legend Biotech Corp.*(1) | | | 7,542 | | | | 425,293 | |
Lexicon Pharmaceuticals, Inc.* | | | 179,972 | | | | 404,937 | |
Ligand Pharmaceuticals, Inc.* | | | 4,049 | | | | 441,300 | |
Madrigal Pharmaceuticals, Inc.*(2) | | | 1,189 | | | | 338,461 | |
Mirum Pharmaceuticals, Inc.* | | | 12,344 | | | | 500,549 | |
Moderna, Inc.* | | | 2,268 | | | | 270,391 | |
Neurocrine Biosciences, Inc.* | | | 2,417 | | | | 342,175 | |
Novavax, Inc.* | | | 21,884 | | | | 280,334 | |
Omniab, Inc. - $12.50 Earnout*(3) | | | 1,295 | | | | 0 | |
Omniab, Inc. - $15.00 Earnout*(3) | | | 1,295 | | | | 0 | |
Phathom Pharmaceuticals, Inc.* | | | 30,078 | | | | 355,522 | |
PTC Therapeutics, Inc.* | | | 8,925 | | | | 302,111 | |
Regeneron Pharmaceuticals, Inc.* | | | 321 | | | | 346,420 | |
Rhythm Pharmaceuticals, Inc.*(2) | | | 7,423 | | | | 357,863 | |
Roivant Sciences Ltd.*(2) | | | 30,467 | | | | 330,567 | |
Sage Therapeutics, Inc.* | | | 28,639 | | | | 313,597 | |
Sarepta Therapeutics, Inc.* | | | 2,635 | | | | 374,802 | |
SpringWorks Therapeutics, Inc.* | | | 8,415 | | | | 302,183 | |
Tarsus Pharmaceuticals, Inc.* | | | 9,938 | | | | 241,394 | |
TG Therapeutics, Inc.*(2) | | | 19,651 | | | | 388,304 | |
Theravance Biopharma, Inc.*(2) | | | 38,386 | | | | 388,082 | |
Travere Therapeutics, Inc.*(2) | | | 45,490 | | | | 433,975 | |
Ultragenyx Pharmaceutical, Inc.* | | | 7,638 | | | | 343,863 | |
United Therapeutics Corp.* | | | 1,145 | | | | 358,717 | |